Hydrocodone Bitartrate/Homatropine Methylbromide Syrup CII
Generic Name and Formulations:
Hydrocodone bitartrate 5mg, homatropine methylbromide 1.5mg; per 5mL.
Various generic manufacturers
Indications for Hydrocodone Bitartrate/Homatropine Methylbromide Syrup:
Use accurate measuring device. ≥12yrs: 5mL every 4–6hrs as needed; max 30mL/24hrs.
Use accurate measuring device. <6yrs: not recommended. 6–11yrs: 2.5mL every 4–6hrs as needed; max 15mL/24hrs.
Risks from concomitant benzodiazepines or other CNS depressants (see Interactions). Risk of life-threatening respiratory depression (esp. in children). Abuse potential (monitor). Head injury, other intracranial lesions or pre-existing increase in intracranial pressure. Acute abdomen. Hypothyroidism. Addison's disease. Prostatic hypertrophy. Urethral stricture. Asthma. Narrow-angle glaucoma. Severe hepatic or renal impairment. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Increased risk of respiratory depression, sedation with benzodiazepines or other CNS depressants (eg, opioids, antihistamines, antipsychotics, anxiolytics, alcohol); avoid. May affect or be affected by MAOIs, TCAs.
Respiratory depression, drowsiness, hypertension, orthostatic hypotension, palpitations, anticholinergic effects, sedation, anxiety, nausea, rash, pruritus.
Formerly known under the brand name Hycodan.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics